NASDAQ:AIFF Firefly Neuroscience (AIFF) Stock Price, News & Analysis $1.19 +0.04 (+3.48%) Closing price 04:00 PM EasternExtended Trading$1.16 -0.03 (-2.94%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Firefly Neuroscience Stock (NASDAQ:AIFF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Firefly Neuroscience alerts:Sign Up Key Stats Today's Range$1.13▼$1.2250-Day Range$0.93▼$1.2852-Week Range$0.62▼$3.15Volume225,202 shsAverage Volume3.74 million shsMarket Capitalization$18.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Firefly Neuroscience, Inc. is a medical technology company focused on applying artificial intelligence to brain health and neurological care. The company develops software designed to analyze electroencephalography (EEG) data and identify objective patterns associated with cognitive and mental health conditions. Its principal offering is the Brain Network Analytics (BNA) platform, which uses machine-learning algorithms to evaluate brain activity and generate biomarkers intended to support the assessment, monitoring and management of conditions such as cognitive impairment and depression. The platform is designed to help clinicians complement conventional evaluations with data-driven insights into brain function. Firefly Neuroscience serves healthcare providers, researchers and other organizations involved in neuroscience and mental health. The company’s technology is focused primarily on clinical and research applications, although specific geographic markets and commercial partnerships may evolve as adoption expands. Firefly Neuroscience is led by Chief Executive Officer Jon Olsen.AI Generated. May Contain Errors. Read More Firefly Neuroscience Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScoreAIFF MarketRank™: Firefly Neuroscience scored higher than 14% of companies evaluated by MarketBeat, and ranked 833rd out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingFirefly Neuroscience has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageFirefly Neuroscience has only been the subject of 1 research reports in the past 90 days.Read more about Firefly Neuroscience's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Firefly Neuroscience is -2.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Firefly Neuroscience is -2.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioFirefly Neuroscience has a P/B Ratio of 2.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.89% of the float of Firefly Neuroscience has been sold short.Short Interest Ratio / Days to CoverFirefly Neuroscience has a short interest ratio ("days to cover") of 5.58.Change versus previous monthShort interest in Firefly Neuroscience has recently decreased by 11.52%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFirefly Neuroscience does not currently pay a dividend.Dividend GrowthFirefly Neuroscience does not have a long track record of dividend growth. News and Social Media3.0 / 5News SentimentN/A News SentimentFirefly Neuroscience has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.Search Interest2 people have searched for AIFF on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Firefly Neuroscience insiders have not sold or bought any company stock.Percentage Held by Insiders6.90% of the stock of Firefly Neuroscience is held by insiders.Percentage Held by Institutions4.96% of the stock of Firefly Neuroscience is held by institutions.Read more about Firefly Neuroscience's insider trading history. Receive AIFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Firefly Neuroscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AIFF Stock News HeadlinesFirefly Neuroscience To Integrate Evoke EEG Platform With RadialOSSeptember 17, 2026 | rttnews.comFirefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain MedicineSeptember 17, 2026 | markets.businessinsider.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.September 24 at 1:00 AM | Paradigm Press (Ad)Firefly Neuroscience and Radial Announce Collaboration to Integrate AI-Powered EEG/ERP Technology into Brain Medicine NetworkSeptember 17, 2026 | quiverquant.comQFirefly Neuroscience's Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain MedicineSeptember 17, 2026 | globenewswire.comFirefly Neuroscience Reports 291% Year-Over-Year Increase in TMS Center Customer Clinical Assessments Using Evoke™ August 5, 2026 | quiverquant.comQFirefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan VolumesAugust 5, 2026 | globenewswire.comFirefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee's Recommendation Backs Broader Access to Key ...July 28, 2026 | tmcnet.comSee More Headlines AIFF Stock Analysis - Frequently Asked Questions How have AIFF shares performed this year? Firefly Neuroscience's stock was trading at $0.8750 at the beginning of 2026. Since then, AIFF shares have increased by 36.6% and is now trading at $1.1950. How were Firefly Neuroscience's earnings last quarter? Firefly Neuroscience, Inc. (NASDAQ:AIFF) issued its quarterly earnings data on Monday, August, 10th. The company reported ($0.10) earnings per share (EPS) for the quarter. The firm had revenue of $0.51 million for the quarter. Firefly Neuroscience had a negative net margin of 506.23% and a negative trailing twelve-month return on equity of 90.17%. When did Firefly Neuroscience's stock split? Firefly Neuroscience shares reverse split on the morning of Tuesday, August 13th 2024.The 1-3 reverse split was announced on Friday, August 9th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. Who are Firefly Neuroscience's major shareholders? Firefly Neuroscience's top institutional shareholders include BlackRock Inc. (1.20%) and Cygnus Capital Advisors LLC (0.28%). Insiders that own company stock include Windsor Private Capital Lp and Gerald James Benoit Jr. View institutional ownership trends. How do I buy shares of Firefly Neuroscience? Shares of AIFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Firefly Neuroscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Firefly Neuroscience investors own include Broadcom (AVGO), Paylocity (PCTY), Analog Devices (ADI), Advanced Micro Devices (AMD), ASML (ASML), Baidu (BIDU) and Bruker (BRKR). Company Calendar Last Earnings8/10/2026Today9/24/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 AIFF's financial health is in the Yellow zone, according to TradeSmith. AIFF has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:AIFF Previous SymbolNASDAQ:AIFF CIK803578 Webfireflyneuro.com Phone(888) 237-6412Fax703-293-7979Employees17Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$19.88 million Net Margins-506.23% Pretax Margin-506.17% Return on Equity-90.17% Return on Assets-72.05% Debt Debt-to-Equity RatioN/A Current Ratio4.87 Quick Ratio4.85 Sales & Book Value Annual Sales$1.80 million Price / Sales10.38 Cash FlowN/A Price / Cash FlowN/A Book Value$0.57 per share Price / Book2.09Miscellaneous Outstanding Shares15,690,000Free Float14,607,000Market Cap$18.67 million OptionableN/A Beta0.55 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:AIFF) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredNASA's ISS Replacement Could Go to This Tiny Space FirmNASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Firefly Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Firefly Neuroscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AIFF Stock Alerts